Erratum: A role for IGF-1R - Targeted therapies in small-cell lung cancer? (Clinical Lung Cancer (2011) 12 (38-42) DOI:10.3816/CLC.2011.n.005);A role for IGF-1R-targeted therapies in small-cell lung cancer?

Clinical Lung Cancer

Volumn 12, Issue 1, 2011, Pages 38-42

  Gately, Kathy ^a   Collins, Ian ^a   Forde, Lydia ^a   Al Alao, Bassel ^a   Young, Vincent ^a   Gerg, Michael ^b   Feuerhake, Friedrich ^b   O'Byrne, Kenneth ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Biomarker; Immunohistochemistry

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LUNG BIOPSY; LUNG RESECTION; LUNG SMALL CELL CANCER; MAINTENANCE THERAPY; MALE; MEDIASTINOSCOPY; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; WESTERN BLOTTING;

EID: 79551507309     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.05.003     Document Type: Erratum

References (15)

1. Fischer B, Marinov M, Arcaro A. Targeting receptor tyrosine kinase signaling in small cell lung cancer (SCLC): what have we learned so far? Cancer Treat Rev 2007;33:391-406.
2. Macaulay VM, Teale JD, Everard MJ, et al. Serum insulin-like growth factor-I levels in patients with small cell lung cancer. Eur J Cancer Clin Oncol 1988;24:1241-2.
3. Nakanishi Y, Mulshine J, Kasprzyk P, et al. Insulin-like growth factor-l can mediate autocrine proliferation of human small cell lung cancer lines in vitro. J Clin Invest 1988;82:354-9.
4. Macaulay VM, Everard MJ, Teale JD, et al. Autocrine function for insulin-like growth factor-1 in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res 1990;50:2511-7.
5. Chang MH, Lee J, Han J, et al. Prognostic role of insulin-like growth factor recep-tor-1 expression in small cell lung cancer. APMIS 2009;117:861-9.
6. Lopez T, Hanahan D. Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 2002;1:339-53.
7. Dunn SE, Hardman RA, Kari FW, Barrett JC. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 1997;57:2687-93.
8. Trojanek J, Ho T, DelValle L, et al. Role of the insulin-like growth factor I/insulin receptor substrate 1axis in Rad51trafficking and DNA repair by homologous recombination. Mol Cell Biol 2003;23:7510-24.
9. Yeh J, Litz J, Hauck P, et al. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt. Lung Cancer 2008;60:166-74.
10. Warshamana-Greene GS, Litz J, Buchdunger E, et al. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy. Clin Cancer Res 2005;11:1563-71.
11. Rosenzweig SA, Atreya HS. Defining the pathway to insulin-like growth factor system targeting in cancer. Biochem Pharmacol 2010;80:1115-24.
12. Karp DD, Paz-Ares LG, Novello S, et al. Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751, 871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. J Clin Oncol 2009;27:2516-22.
13. Jassem J, Langer CJ, Karp DD et al. Randomized, open label, phase III trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC). J Clin Oncol 2010;28(15 suppl): 539s (abstract 7500).
14. Gridelli C, Rossi A, Bareschino MA, et al. The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer. Expert Opin Investig Drugs 2010;19:631-9.
15. Dziadziuszko R, Merrick DT, Witta SE, et al. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. J Clin Oncol 2010;28:2174-80.